Eris enters dermatology therapy, acquires Oaknet Healthcare for Rs 6,500 million
Eris Lifesciences on Tuesday announced acquisition of the trademark Zomelis, for Vildagliptin-based formulations, and its associated trademarks from Novartis AG, Switzerland, for a consideration of $13 million (roughly Rs 93 crore).
Eris Lifesciences, a leading pharmaceutical company and PlexusMD, India’s largest professional networking platform for doctors announced their partnership for a unique artificial intelligence (AI) powered learning platform named “Saarthi”.
Eris Lifesciences was up 3% at Rs 817 on the BSE in early morning trade, trading higher for the fifth straight trading day.